Vascular Therapies
Vascular Therapies is a biotechnology company focused on improving patient outcomes by reducing surgical stenosis in patients with kidney and vascular disease. The company has developed Sirogen™, an investigational sirolimus formulation for local, perivascular drug delivery. Sirogen™ is currently undergoing clinical trials to determine its safety and effectiveness in improving vascular access outcomes in patients requiring an arteriovenous fistula for hemodialysis.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
1
tools in use
Monthly traffic
96
organic / mo
Sign up free to see all 5 verified contacts at Vascular Therapies
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- RR
Rakesh Raghubanshi
Senior Director · Operations
EmailPhone - PB
Paul Barkofsky
Vice President, New Product Development · General Business & Management
EmailPhone - JM
John McDermott
CEO · Other
EmailPhone - MH
Maureen Harrison
Vice President Quality Assurance · Information Technology
EmailPhone - RE
Ronald E. Eggan
Sr Director of Manufacturing · Other
EmailPhone
Showing 5 of 5 verified contacts
Top roles at Vascular Therapies
5 distinct titles indexed · top 5 shown.
- 1ceo
- 1senior director
- 1sr director of manufacturing
- 1vice president quality assurance
- 1vice president, new product development
Sign up to unlock all 5 contacts at Vascular Therapies
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Vascular Therapies
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.